NCT00541801

Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography

Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography in Patients With Cytostatic Therapies

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: —
• Sponsor: Luzerner Kantonsspital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In this study, the investigators sought to determine whether an acoustic cardiographic assessment of heart function is equivalent to Doppler-echocardiography in patients who are treated with cardio-toxic cytostatic agents.

Detailed description

Patients receiving cardio-toxic cytostatic agents are examined by Doppler-echocardiography and acoustic cardiography before, during, and after the cytostatic treatment. Doppler-echocardiography measures ejection fraction, TDI, speckle tracking, and further parameters. Acoustic cardiography (Audicor, Inovise Medical Inc., Portland, USA) simultaneously integrates heart sounds and single-channel electrocardiography input to generate multiple parameters that correlate to established hemodynamic measures. Heart function as assessed by Doppler-echocardiography is then compared to the heart function as assessed by Audicor ECG.

Conditions

• Heart Failure, Congestive
• Antineoplastic Agents

Interventions

Type	Name	Description
DEVICE	Doppler-echocardiography and acoustic cardiography	Patients receive a Doppler-echocardiography and an acoustic cardiography

Timeline

• Start date: 2007-03-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2007-10-10
• Last updated: 2011-06-27

Locations

1 site across 1 country: Switzerland